Newswise Feature Channel: Diabetes

Type 2 Diabetes Medication Improves Liver Health in Mice Fed High Fat Diet

American Physiological Society (APS) — Fri, 06 Sep 2024 18:05:05 EST

Disruptions to Cholesterol in Cells Is an Early Sign of Beta Cell Damage in Model of Type 2 Diabetes

American Physiological Society (APS) — Fri, 06 Sep 2024 17:05:44 EST

MSU expert: How much do presidential debates matter?

Michigan State University — Fri, 06 Sep 2024 15:05:01 EST

Vice President Kamala Harris and former President Donald Trump are set to square off for their first presidential debate matchup on September 10 in Philadelphia, Pennsylvania.

UC Irvine, USC scientists begin research effort for damaged brain region treatments

University of California, Irvine — Thu, 05 Sep 2024 12:05:30 EST

With newly awarded funding from the National Science Foundation, researchers at the University of California, Irvine and the Keck School of Medicine of USC will seek to revolutionize the treatment of neurological diseases through intelligent biocomputing. The four-year, $2 million grant is part of NSF's Emerging Frontiers in Research and Innovation program, which funds cutting-edge science pushing the boundaries of human knowledge.

Millions of people with diabetic foot ulcers could benefit from new research discovery

Michigan State University — Wed, 04 Sep 2024 16:15:39 EST

People with chronic diabetic foot ulcers could soon have a new way to treat their wounds for faster healing and fewer hospital stays. Researchers from Michigan State University and South Shore Hospital have uncovered that the combination of two common diabetes drugs -- injectable insulin and orally-administered metformin -- increases the amount of metformin at the wound site.

Ochsner Digital Medicine elevates program with a focus on total cardiometabolic health

Ochsner Health — Wed, 04 Sep 2024 13:05:50 EST

Ochsner Digital Medicine is announcing an added capability to its cardiometabolic solution: comprehensive weight management care.

Penn study finds taking semaglutide for weight management does not increase risk of depression or suicidal behavior in people without known major psychopathology

Perelman School of Medicine at the University of Pennsylvania — Tue, 03 Sep 2024 11:00:00 EST

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine. Both the Food and Drug Administration (FDA) and the European Medicines Agency are actively monitoring the psychiatric safety of semaglutide and similar medications after post marketing surveillance reports of depression, suicidal thoughts (ideation), and suicidal behavior in patients taking the drugs for the management of type 2 diabetes or obesity.

Primary Care Providers Urged to Assist Patients Who Engage in Emotional Eating

Wolters Kluwer Health: Lippincott — Wed, 28 Aug 2024 12:30:53 EST

Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts.

New technology 'lights up' bacteria in wounds for better infection prevention

Keck Medicine of USC — Tue, 27 Aug 2024 12:00:51 EST

New Keck Medicine of USC research published in Advances in Wound Care suggests there may be a more effective method to detect bacteria during wound debridement.

Mount Sinai Health System Researcher Receives $4 Million Grant From NIH to Study the Role of the Mammary Gland Secretome in Metabolic Health

Mount Sinai Health System — Tue, 27 Aug 2024 09:30:07 EST

Investigating a new frontier in understanding diseases like obesity and type 2 diabetes.

Dementia risk similar with SGLT2 inhibitors and dulaglutide

American College of Physicians (ACP) — Mon, 26 Aug 2024 17:00:00 EST

A nation-wide, population-based cohort study compared the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dulaglutide on risk for dementia in older patients with type 2 diabetes (T2D).

Ochsner Digital Medicine teams up with AmeriHealth Caritas Louisiana to improve treatment of hypertension, Type 2 diabetes

Ochsner Health — Mon, 26 Aug 2024 13:05:35 EST

Ochsner Digital Medicine has teamed up with AmeriHealth Caritas Louisiana to offer digital medicine services to the health plan's members. Utilizing remote patient management (RPM), Ochsner Digital Medicine and AmeriHealth Caritas Louisiana will work together to help members with certain chronic conditions better manage their health and improve their quality of life.

Mental health and chronic diabetes complications strongly linked both ways, study finds

Michigan Medicine - University of Michigan — Thu, 22 Aug 2024 19:30:11 EST

When a person has chronic diabetes complications - such as heart attack, stroke and nerve damage - they are more likely to have a mental health disorder, and vice versa, according to a study. Researchers say the findings highlight a need for clinicians to actively screen for mental health disorders in patients with diabetes in addition to screening for chronic complications, which is the recommended standard of care in diabetes.

New Program to Expand Access to Eye Care for Underserved Delaware Residents

American Academy of Ophthalmology (AAO) — Thu, 22 Aug 2024 17:00:28 EST

American Academy of Ophthalmology, through its Foundation and EyeCare America program, launches pilot program with Henrietta Johnson Medical Center and Eyenuk, Inc.

New Program to Expand Access to Eye Care for Underserved Delaware Residents

American Academy of Ophthalmology (AAO) — Thu, 22 Aug 2024 12:00:56 EST

American Academy of Ophthalmology, through its Foundation and EyeCare America program, launches pilot program with Henrietta Johnson Medical Center and Eyenuk, Inc.

FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes

Florida State University — Thu, 22 Aug 2024 11:05:50 EST

New research led by Ayyalusamy Ramamoorthy, a professor at the FAMU-FSU College of Engineering and the Florida State University-headquartered National High Magnetic Field Laboratory, shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to Type 2 diabetes.

Reviews of Sweeteners' Impact on Body Weight Focus on Different Studies and Produce Different Findings

Institute for the Advancement of Food and Nutrition Sciences — Wed, 21 Aug 2024 11:30:19 EST

Published reviews of the impact of low- and no-calorie sweetener consumption on body weight differ because they are based on studies that ask different questions.

Endocrine Society honors endocrinology field's leaders with 2025 Laureate Awards

Endocrine Society — Wed, 21 Aug 2024 09:00:10 EST

The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2025 Laureate Awards, the top honors in the field.

How do GLP-1 weight loss drugs affect the liver?

Michigan Medicine - University of Michigan — Tue, 20 Aug 2024 10:30:10 EST

Drugs such as Ozempic, Rybelsus and Wegovy have made news for their abilities to treat diabetes and encourage weight loss. To give a clearer understanding of the benefits and risks of GLP-1 agonists for patients with liver disease, Robert Fontana, M.D., a Michigan Medicine hepatologist, answered our questions.

Type 2 diabetes increased by almost 20% over a decade

University of Georgia — Tue, 20 Aug 2024 08:05:21 EST

Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia.